Cargando…
Composite vector formulation for multiple siRNA delivery as a host targeting antiviral in a cell culture model of hepatitis C virus (HCV) infection†
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease and cancer worldwide. RNA interference (RNAi)-based gene therapies have emerged recently as a promising tool to treat chronic viral infections. Indeed, small interfering RNAs (siRNAs) provide an opportunity to target host fa...
Autores principales: | Crouchet, E., Saad, R., Affolter-Zbaraszczuk, C., Ogier, J., Baumert, T. F., Schuster, C., Meyer, F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613424/ https://www.ncbi.nlm.nih.gov/pubmed/32263854 http://dx.doi.org/10.1039/c6tb01718e |
Ejemplares similares
-
Intranasal Delivery of Antiviral siRNA
por: Barik, Sailen
Publicado: (2010) -
Hepatitis C Virus (HCV)–Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design
por: Wrensch, Florian, et al.
Publicado: (2018) -
Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection
por: Zeisel, Mirjam B., et al.
Publicado: (2015) -
Extracellular lipid-free apolipoprotein E inhibits HCV replication and induces ABCG1-dependent cholesterol efflux
por: Crouchet, Emilie, et al.
Publicado: (2017) -
Local siRNA delivery by non-viral vectors
por: Beilvert, F., et al.
Publicado: (2012)